-
-
Deeply committed to developing precision medicine
We are focusing on the development of targeted therapies, especially the next-generation targeted therapies. Using artificial intelligence drug design (AIDD) and structural-based drug design (SBDD) technologies, we are committed to developing Best-In-Class small molecule targeted innovative drugs.
Science & Platform -
Develop high-quality targeted innovative drugs to create new therapeutic options for patients worldwide
Our current R&D programs are mainly focused on the field of targeted oncology, and may involve more therapeutic fields in the future.
Our Pipeline -
Leverage global resources to efficiently promote R&D programs